Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
43.58 USD | -2.49% |
|
+2.90% | +96.14% |
Business Summary
Number of employees: 385
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medicines for Cellular Metabolism
100.0
%
| 14 | 100.0 % | 27 | 100.0 % | +88.36% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 14 | 100.0 % | 27 | 100.0 % | +88.36% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Brian Goff
CEO | Chief Executive Officer | 55 | 22-08-07 |
Cecilia Jones
DFI | Director of Finance/CFO | 49 | 22-09-25 |
Jacqualyn Fouse
CHM | Chairman | 62 | 17-12-04 |
Sarah Gheuens
CTO | Chief Tech/Sci/R&D Officer | 45 | 19-11-30 |
Clive Patience
CTO | Chief Tech/Sci/R&D Officer | 60 | 17-05-31 |
David Schenkein
BRD | Director/Board Member | 66 | 09-07-31 |
Investor Relations Contact | - | - | |
Charlie Newman
PRN | Corporate Officer/Principal | - | 21-12-31 |
Ellen Lopresti
HRO | Human Resources Officer | - | 16-12-31 |
T. Washburn
AUD | Comptroller/Controller/Auditor | 43 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Capello
BRD | Director/Board Member | 69 | 23-05-31 |
Director/Board Member | 64 | 14-12-08 | |
May Kin Ho
BRD | Director/Board Member | 71 | 15-06-22 |
David Schenkein
BRD | Director/Board Member | 66 | 09-07-31 |
Jacqualyn Fouse
CHM | Chairman | 62 | 17-12-04 |
David Scadden
BRD | Director/Board Member | 71 | 17-05-26 |
Brian Goff
CEO | Chief Executive Officer | 55 | 22-08-07 |
Cynthia Smith
BRD | Director/Board Member | 55 | 22-08-10 |
Rahul Ballal
BRD | Director/Board Member | 46 | 22-08-10 |
Catherine Owen
BRD | Director/Board Member | 53 | 23-06-12 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 72,989,377 | 55,931,414 ( 76.63 %) | 16,216,411 ( 22.22 %) | 76.63 % |
Company contact information
![address Agios Pharmaceuticals, Inc.(AGIO)](https://cdn.zonebourse.com/static/address/13709228.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+96.14% | 2.54B | |
+16.77% | 122B | |
+22.02% | 116B | |
+22.18% | 27.03B | |
-21.76% | 20.36B | |
-16.89% | 16.43B | |
-18.57% | 15.91B | |
-44.74% | 15.6B | |
+61.78% | 14.94B | |
+3.13% | 13.59B |
- Stock Market
- Equities
- AGIO Stock
- Company Agios Pharmaceuticals, Inc.